pneumococcal conjugate vaccine


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

pneumococcal conjugate vaccine

A pneumococcal vaccine used for active immunization of infants and toddlers.
See: PCV7, PCV13
See also: vaccine
References in periodicals archive ?
Considering the other available pneumococcal conjugate vaccine PCV-13 which incorporates 13 pneumococcal serotypes, present study showed a coverage rate of 45% carriage serotypes, which suggests approximately 5% increase in the coverage as compared to the PCV-10.
Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: The Palestinian-Israeli Collaborative Research (PICR).
Schaffner et al., "Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance," The Lancet Infectious Diseases, vol.
Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.
[9.] Fireman B, Black SB, Shinefield HR, et al Impact of the pneumococcal conjugate vaccine on otitis media.
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.
Prevention of pneumococcal disease among infants and children--use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine--recommendations of the Advisory Committee on Immunization Practices (ACIP).
Fritzell added that in response to this epidemiologic shift, Pfizer developed the 13-valent pneumococcal conjugate vaccine, to help provide coverage against even more disease-causing serotypes.
PCV: Pneumococcal conjugate vaccine (PCV) is a vaccine used to protect infants and young children against disease caused by the bacterium Streptococcus pneumoniae (pneumococcus).
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999; 180: 1171-1176.

Full browser ?